Abstract

This investigation will examine the role of diglyceride and glutathione metabolism in the regulation of parathyroid cell function. Collagenase-dispersed bovine parathyroid cells will be used throughout. The studies will focus initially on the role of calcium-induced changes in diglyceride formation and resultant effects on phosphatidyl-inositol levels, protein phosphorylation and parathyroid hormone secretion. The approach will be to assess the rate of radiolabeled glycerol incorporation into diglyceride and related metabolites. Lipids will be separated by means of thin layer and high performance liquid chromatography and radiolabel content determined by liquid scintillation spectroscopy. The metabolism of the synthetic diglyceride 1-oleoyl-2-acetylglycerol by the parathyroid cells into phosphatidic acid phosphatidylinositol will be determined. Protein phosphorylation/dephosphorylation patterns of cells incubated at various extracellular calcium ion concentrations or cells treated with phorbol myristate acetate, synthetic diglyceride or isoproterenol will be evaluated. The phosphoproteins will be separated by two-dimensional electrophoresis and visualized by radioautography. Proteins in which the phosphorylation/dephosphorylation changes coincide with changes in hormone secretion will be selected for further evaluation and characterization. Multiple phosphorylation sites within secretion-associated proteins will be evaluated by tryptic digestion and separation of the phosphopeptides by thin layer peptide mapping and high performance liquid chromatography. Specific phosphoamino acids will be identified by acid hydrolysis followed by two-dimensional thin layer electrophoresis. The subcellular localization of secretion-associated phosphopeptides will be evaluated. The participation of myosin light chain phosphorylation in the control of hormone secretion will be determined. The involvement of calcium-mediated changes in hexose monophosphate shunt activity and reduced glutathione levels in hormone secretion will be determined. The role of glutathione reductase in hormone secretion will be evaluated by inhibition with BCNU. The contribution of mitochondria (NADPH sensitive) and microsomal (reduced glutathione sensitive) calcium uptake systems to parathyroid cell calcium homeostasis and parathyroid hormone secretion will be measured. The results will be integrated to provide information on the manner in which changes in extracellular calcium influence the participation of diglyceride-activated protein kinase C, cyclic AMP-dependent protein kinase and reduced glutathione in the control of parathyroid hormone secretion.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK030178-08
Application #
3229323
Study Section
General Medicine B Study Section (GMB)
Project Start
1982-01-01
Project End
1989-12-31
Budget Start
1989-01-01
Budget End
1989-12-31
Support Year
8
Fiscal Year
1989
Total Cost
Indirect Cost

  Institution

Name
Washington University
Department
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130

  Publications

Slatopolsky, Eduardo (2011) The intact nephron hypothesis: the concept and its implications for phosphate management in CKD-related mineral and bone disorder. Kidney Int Suppl :S3-8
Takahashi, Fumiaki; Denda, Masashi; Finch, Jane L et al. (2002) Hyperplasia of the parathyroid gland without secondary hyperparathyroidism. Kidney Int 61:1332-8
Dusso, A S; Pavlopoulos, T; Naumovich, L et al. (2001) p21(WAF1) and transforming growth factor-alpha mediate dietary phosphate regulation of parathyroid cell growth. Kidney Int 59:855-65
Huang, Z; Cheng, S L; Slatopolsky, E (2001) Sustained activation of the extracellular signal-regulated kinase pathway is required for extracellular calcium stimulation of human osteoblast proliferation. J Biol Chem 276:21351-8
Holliday, L S; Gluck, S L; Slatopolsky, E et al. (2000) 1,25-Dihydroxy-19-nor-vitamin D(2), a vitamin D analog with reduced bone resorbing activity in vitro. J Am Soc Nephrol 11:1857-64
Brown, A J; Finch, J; Takahashi, F et al. (2000) Calcemic activity of 19-Nor-1,25(OH)(2)D(2) decreases with duration of treatment. J Am Soc Nephrol 11:2088-94
Slatopolsky, E; Brown, A; Dusso, A (1999) Pathogenesis of secondary hyperparathyroidism. Kidney Int Suppl 73:S14-9
Brown, A J; Ritter, C S; Finch, J L et al. (1999) Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate. Kidney Int 55:1284-92
Slatopolsky, E; Dusso, A; Brown, A J (1999) The role of phosphorus in the development of secondary hyperparathyroidism and parathyroid cell proliferation in chronic renal failure. Am J Med Sci 317:370-6
Huang, Z; Ritter, C; Brown, A et al. (1999) Cloning and localization of Rab3 isoforms in bovine, rat, and human parathyroid glands. Biochem Biophys Res Commun 255:645-51

Showing the most recent 10 out of 42 publications